Bollwage previously served as Director of Global Regulatory Science at Bristol-Myers Squibb and as Executive Director and Regulatory Counsel of Global Regulatory Intelligence at i3 Research.
"Brian brings a wealth of global regulatory leadership experience in both the CRO and pharmaceutical industries," stated Theorem Clinical Research Chief Executive Officer John Potthoff. "I am certain that he will excel in his new role."
Bollwage is a food and drug law expert with published articles in Regulatory Affairs Focus, PharmaVOICE and Applied Clinical Trials, among others. A graduate of Rutgers Law School, he currently serves as an associate professor of food and drug law at Temple University in Philadelphia. Bollwage also holds a Master of Business Administration, specializing in pharmaceutical/chemical studies, and a Master of Science.